Roche Holding AG (OTCQX International Premier:RHHVF)

219.20
Delayed Data
As of 1:31pm ET
 -3.42 / -1.54%
Today’s Change
219.20
Today|||52-Week Range
276.80
-12.67%
Year-to-Date
Biogen (BIIB) Q1 Earnings Beat, Sales Miss, Shares Down
Apr 24 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Gets Priority Review for Lung Cancer
Apr 19 / Zacks.com - Paid Partner Content
Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus
Apr 23 / Zacks.com - Paid Partner Content
FDA Nods to AstraZeneca's Tagrisso for First-Line NSCLC
Apr 19 / Zacks.com - Paid Partner Content
FDA Nods to AstraZeneca's Tagrisso for First-Line NSCLC (revised)
Apr 23 / Zacks.com - Paid Partner Content
Roche Hemophilia Drug Gets Breakthrough Therapy Designation
Apr 18 / Zacks.com - Paid Partner Content
Roche Creates Video Game for Multiple Sclerosis Patients
Apr 23 / GuruFocus News - Paid Partner Content
What's in Store for Novartis (NVS) This Earnings Season?
Apr 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR
Apr 20 / Zacks.com - Paid Partner Content
Celldex's Phase II Breast Cancer Study Fails, Shares Plunge
Apr 17 / Zacks.com - Paid Partner Content
What's in Store for Biogen (BIIB) This Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
Bristol-Myers Reports Positive Data in NSCLC Trial on Opdivo
Apr 16 / Zacks.com - Paid Partner Content